Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Observer-blind Study to Assess the Safety, Reactogenicity and Immunogenicity of Different Formulations of GSK Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women
Brief Summary: The purpose of this study is to evaluate the safety, reactogenicity and immunogenicity of different formulations of a single intramuscular dose of GSK Biologicals' investigational RSV vaccine, in healthy, non-pregnant women aged 18 to 45 years.


Options:
A: Arm Label: Group 1: RSV vaccine; Type: EXPERIMENTAL; Interventions: Biological: RSV ΔNS2 Δ1313 I1314L Vaccine | Arm Label: Group 1: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Arm Label: Group 2: RSV vaccine; Type: EXPERIMENTAL; Interventions: Biological: RSV ΔNS2 Δ1313 I1314L Vaccine | Arm Label: Group 2: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Arm Label: Group 3: RSV vaccine; Type: EXPERIMENTAL; Interventions: Biological: RSV ΔNS2 Δ1313 I1314L Vaccine | Arm Label: Group 3: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Arm Label: Group 4: RSV vaccine; Type: EXPERIMENTAL; Interventions: Biological: RSV ΔNS2 Δ1313 I1314L Vaccine | Arm Label: Group 4: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: RSV ΔNS2 Δ1313 I1314L Vaccine; Assigned to Arm(s): Group 1: RSV vaccine, Group 2: RSV vaccine, Group 3: RSV vaccine, Group 4: RSV vaccine | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Group 1: Placebo, Group 2: Placebo, Group 3: Placebo, Group 4: Placebo
B: Arm Label: No treatment; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 3804-250A lotion; Type: EXPERIMENTAL; Interventions: Drug: 3804-250A | Intervention Type: DRUG; Name: 3804-250A; Assigned to Arm(s): 3804-250A lotion
C: Arm Label: RSV vaccine formulation 1 Group; Type: EXPERIMENTAL; Interventions: Biological: RSV vaccine GSK3003895A (formulation 1) | Arm Label: RSV vaccine formulation 2 Group; Type: EXPERIMENTAL; Interventions: Biological: RSV vaccine GSK3003898A (formulation 2) | Arm Label: RSV vaccine formulation 3 Group; Type: EXPERIMENTAL; Interventions: Biological: RSV vaccine GSK3003899A (formulation 3) | Arm Label: Boostrix Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: Boostrix | Intervention Type: BIOLOGICAL; Name: RSV vaccine GSK3003895A (formulation 1); Assigned to Arm(s): RSV vaccine formulation 1 Group | Intervention Type: BIOLOGICAL; Name: RSV vaccine GSK3003898A (formulation 2); Assigned to Arm(s): RSV vaccine formulation 2 Group | Intervention Type: BIOLOGICAL; Name: RSV vaccine GSK3003899A (formulation 3); Assigned to Arm(s): RSV vaccine formulation 3 Group | Intervention Type: BIOLOGICAL; Name: Boostrix; Assigned to Arm(s): Boostrix Group
D: Arm Label: Vaccine arm; Type: ACTIVE_COMPARATOR; Interventions: Biological: ShanChol | Arm Label: Vaccine plus hygiene and safe water arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Vaccine and behaviour | Arm Label: Non-intervention arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BIOLOGICAL; Name: ShanChol; Assigned to Arm(s): Vaccine arm | Intervention Type: BEHAVIORAL; Name: Vaccine and behaviour; Assigned to Arm(s): Vaccine plus hygiene and safe water arm

Answer: C